---
title: PSI vs MPREX
slug_a: appian
slug_b: mprex
site: cro
review_signal_gate: closed
canonical_path: /compare/appian/mprex
generated_by: BioBM Editorial AI
---

# PSI vs MPREX

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

PSI (appian) is listed for cro. PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.

Services: 3. Modalities: 3. Indications: 9. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in indications (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

MPREX (mprex) is listed for cro. MPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety.

Services: 4. Modalities: 0. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.